Literature DB >> 7568084

Redirecting the specificity of ubiquitination by modifying ubiquitin-conjugating enzymes.

M M Gosink1, R D Vierstra.   

Abstract

Depletion of specific cellular proteins is a powerful tool in biological research and has many medical and agricultural benefits. In contrast to genetic methods currently available to attenuate protein levels, we describe an alternative approach that redirects the ubiquitin-dependent proteolytic pathway to facilitate specific proteolytic removal. Degradation via the ubiquitin pathway requires the prior attachment of multiple ubiquitins to the target protein. This attachment is accomplished, in part, by a family of enzymes designated E2s (or ubiquitin-conjugating enzymes), some of which use domains near their C termini for target recognition. Here, we demonstrate that E2 target recognition can be redefined by engineering E2s to contain appropriate protein-binding peptides fused to their C termini. In five dissimilar examples, chimeric E2s were created that recognized and ubiquitinated their respective binding partners with high specificity. We also show that ubiquitination of one protein targeted by this method led to its ATP-dependent degradation in vitro. Thus, by exploiting interacting domains derived from natural and synthetic ligands, it may be possible to design E2s capable of directing the selective removal of many intracellular proteins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7568084      PMCID: PMC40935          DOI: 10.1073/pnas.92.20.9117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

Review 1.  The ubiquitin system for protein degradation.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1992       Impact factor: 23.643

2.  Multiple forms of the 20 S multicatalytic and the 26 S ubiquitin/ATP-dependent proteases from rabbit reticulocyte lysate.

Authors:  L Hoffman; G Pratt; M Rechsteiner
Journal:  J Biol Chem       Date:  1992-11-05       Impact factor: 5.157

Review 3.  The ubiquitin-conjugation system.

Authors:  S Jentsch
Journal:  Annu Rev Genet       Date:  1992       Impact factor: 16.830

4.  Epitope tagging and protein surveillance.

Authors:  P A Kolodziej; R A Young
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

5.  Cloning of a 16-kDa ubiquitin carrier protein from wheat and Arabidopsis thaliana. Identification of functional domains by in vitro mutagenesis.

Authors:  M L Sullivan; R D Vierstra
Journal:  J Biol Chem       Date:  1991-12-15       Impact factor: 5.157

6.  A ribonuclease S-peptide antagonist discovered with a bacteriophage display library.

Authors:  G P Smith; D A Schultz; J E Ladbury
Journal:  Gene       Date:  1993-06-15       Impact factor: 3.688

7.  Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain.

Authors:  M Treier; L M Staszewski; D Bohmann
Journal:  Cell       Date:  1994-09-09       Impact factor: 41.582

8.  Transforming growth factor-alpha expression produces only morphological transformants of diploid human fibroblasts.

Authors:  W H Brondyk; G C Kujoth; W E Fahl
Journal:  Cancer Res       Date:  1993-05-01       Impact factor: 12.701

9.  Heat-inducible degron: a method for constructing temperature-sensitive mutants.

Authors:  R J Dohmen; P Wu; A Varshavsky
Journal:  Science       Date:  1994-03-04       Impact factor: 47.728

Review 10.  Gene therapy for human immunodeficiency virus infection: genetic antiviral strategies and targets for intervention.

Authors:  B Dropulić; K T Jeang
Journal:  Hum Gene Ther       Date:  1994-08       Impact factor: 5.695

View more
  15 in total

1.  A mutant deubiquitinating enzyme (Ubp-M) associates with mitotic chromosomes and blocks cell division.

Authors:  S Y Cai; R W Babbitt; V T Marchesi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

2.  Targeted modification and transportation of cellular proteins.

Authors:  P Colas; B Cohen; P Ko Ferrigno; P A Silver; R Brent
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

3.  Interaction of the tail with the catalytic region of a class II E2 conjugating enzyme.

Authors:  Nadine Merkley; Gary S Shaw
Journal:  J Biomol NMR       Date:  2003-06       Impact factor: 2.835

4.  An auxin-based degron system for the rapid depletion of proteins in nonplant cells.

Authors:  Kohei Nishimura; Tatsuo Fukagawa; Haruhiko Takisawa; Tatsuo Kakimoto; Masato Kanemaki
Journal:  Nat Methods       Date:  2009-11-15       Impact factor: 28.547

Review 5.  Proteolysis in plants: mechanisms and functions.

Authors:  R D Vierstra
Journal:  Plant Mol Biol       Date:  1996-10       Impact factor: 4.076

6.  Role of UEV-1, an inactive variant of the E2 ubiquitin-conjugating enzymes, in in vitro differentiation and cell cycle behavior of HT-29-M6 intestinal mucosecretory cells.

Authors:  E Sancho; M R Vilá; L Sánchez-Pulido; J J Lozano; R Paciucci; M Nadal; M Fox; C Harvey; B Bercovich; N Loukili; A Ciechanover; S L Lin; F Sanz; X Estivill; A Valencia; T M Thomson
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

7.  Biochemical characterization of Caenorhabditis elegans UBC-1: self-association and auto-ubiquitination of a RAD6-like ubiquitin-conjugating enzyme in vitro.

Authors:  D S Leggett; P M Candido
Journal:  Biochem J       Date:  1997-10-15       Impact factor: 3.857

8.  Eradication of pathogenic beta-catenin by Skp1/Cullin/F box ubiquitination machinery.

Authors:  Yunyun Su; Shinji Ishikawa; Masayuki Kojima; Bo Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-16       Impact factor: 11.205

Review 9.  Targeting proteins for degradation.

Authors:  Erin K Schrader; Kristine G Harstad; Andreas Matouschek
Journal:  Nat Chem Biol       Date:  2009-11       Impact factor: 15.040

10.  Cue1p is an activator of Ubc7p E2 activity in vitro and in vivo.

Authors:  Omar A Bazirgan; Randolph Y Hampton
Journal:  J Biol Chem       Date:  2008-03-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.